Marvell Technology Officer Files Form 144 to Sell $1.87M in Common Stock Under Rule 10b5-1 Plan
Marvell Technology, Inc.
Subscribe to track MRVL
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Filing Analysis: Marvell Technology, Inc. (NASDAQ: MRVL)
• Insider: Chris Koopmans (KOOPMANS FAMILY TRUST U/A DTD 03/28/2013) • Title/Role: Officer • Proposed Sale: 10,000 Common Shares • Approx. Market Value: $1,869,674.00 (~$186.97/share) • Approx. Sale Date: November 2, 2026 • Trading Plan: Rule 10b5-1 plan adopted June 16, 2026 • Broker: Morgan Stanley Smith Barney LLC • Significance: Low (Routine scheduled programmatic sale representing a negligible fraction of shares outstanding)
Comprehensive Analysis
Executive Summary
On November 2, 2026, Chris Koopmans, an Officer of Marvell Technology, Inc. (NASDAQ: MRVL), filed Form 144 disclosing a proposed sale of 10,000 shares of common stock through the KOOPMANS FAMILY TRUST U/A DTD 03/28/2013. The aggregate market value of the proposed transaction is $1,869,674.00, implying an estimated price of $186.97 per share.
Transaction Details
- Filer: Chris Koopmans / KOOPMANS FAMILY TRUST U/A DTD 03/28/2013
- Position: Officer
- Number of Shares: 10,000 shares of Common Stock
- Aggregate Market Value: $1,869,674.00
- Approximate Sale Date: November 2, 2026
- Nature of Acquisition: Restricted stock and Performance Shares acquired via issuer vesting between April 15, 2026, and October 15, 2026.
- Trading Plan: Pre-established Rule 10b5-1 trading plan adopted on June 16, 2026.
Historical Selling Activity
Over the past three months, the trust has executed consistent monthly sales of 10,000 shares:
- October 1, 2026: 10,000 shares sold for gross proceeds of $2,620,515.00
- September 1, 2026: 10,000 shares sold for gross proceeds of $2,032,703.00
- August 3, 2026: 10,000 shares sold for gross proceeds of $1,805,004.00
Market Impact & Trading Significance
The trading significance of this filing is classified as Low. The proposed sale of 10,000 shares represents approximately 0.001% of Marvell's 876,900,000 outstanding shares. Given that this sale is part of an ongoing, pre-scheduled Rule 10b5-1 program with identical volumes executed monthly, it reflects standard executive diversification rather than a discretionary signal on company fundamentals.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.